Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study
Joakim Dillner(Karolinska University Hospital), Thomas Iftner(Institute of Medical Microbiology and Hygiene)
Cited by 630
Related Papers
Overview of the European and North American studies on HPV testing in primary cervical cancer screening
|International Journal of Cancer|2006|1.1k
A systematic review of the prevalence of mucosal and cutaneous human papillomavirus types
|Virology|2013|317
Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients
|British Journal of Cancer|2003|302
Epigenome-based cancer risk prediction: rationale, opportunities and challenges
|Nature Reviews Clinical Oncology|2018|173